Literature DB >> 1779966

Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element.

M Ernst1, M G Parker, G A Rodan.   

Abstract

Although a small number of estrogen receptors (ER) were visualized in osteoblastic cells, and estradiol (E2) has some effects on osteoblasts in vitro, the direct action of E2 on osteoblasts has not been fully established. To determine the presence of functional ER in osteoblasts, we transfected cells with a plasmid containing the chloramphenicol acetyl transferase (CAT) reporter gene and the estrogen-responsive element (ERE) from the vitellogenin A2 gene. E2-dependent induction of CAT activity was determined 48 h after transient transfection and subsequent treatment with 10-100 nM 17 beta-E2. 17 beta-E2, but not 17 alpha-E2, dihydrotestosterone, or progesterone, induced CAT activity in a dose-dependent manner (up to 6-fold) in rat calvarial fraction-3, RCT-3, PyMS, and UMR-106 cells as well as in the human osteosarcoma cell line SaOS-2/B-10. In contrast, E2 had no effect on the induction of CAT activity in the preosteoblastic cell lines RCT-1 and TRAB-11, in the rat osteosarcoma cell line ROS 17/2.8, and in the fibroblastic cell lines BALB-c/3T3 and NRK. Over-expression of ER using a simian virus-40-based expression vector not only conferred or enhanced E2-dependent induction of CAT in all cell types, but augmented E2-dependent expression of insulin-like growth factor-I and E2-stimulated DNA synthesis in primary calvarial and PyMS osteoblastic cells, respectively. These data show the presence of low levels of functional endogenous ER in some, but not all, osteoblastic cells and suggest that the abundance of ER may be rate limiting in the action of E2 on these cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1779966     DOI: 10.1210/mend-5-11-1597

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  8 in total

1.  Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen.

Authors:  B Kristensen; B Ejlertsen; H T Mouridsen; K W Andersen; J B Lauritzen
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 2.  Estrogen receptor interaction with estrogen response elements.

Authors:  C M Klinge
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

3.  Functional estrogen receptors in a human preosteoclastic cell line.

Authors:  G Fiorelli; F Gori; M Petilli; A Tanini; S Benvenuti; M Serio; P Bernabei; M L Brandi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

4.  Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta.

Authors:  B Stein; M X Yang
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

5.  Petroleum ether extract of Cissus quadrangularis (LINN) stimulates the growth of fetal bone during intra uterine developmental period: a morphometric analysis.

Authors:  Bhagath Kumar Potu; Muddanna S Rao; N Gopalan Kutty; Kumar M R Bhat; Mallikarjuna Rao Chamallamudi; Soubhagya Ranjan Nayak
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

6.  Alterations in estrogen levels during development affects the skeleton: use of an animal model.

Authors:  S Migliaccio; R R Newbold; J A McLachlan; K S Korach
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

7.  A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic.

Authors:  S Jobling; T Reynolds; R White; M G Parker; J P Sumpter
Journal:  Environ Health Perspect       Date:  1995-06       Impact factor: 9.031

8.  Inhibitory effects of tamoxifen and doxorubicin, alone and in combination, on the proliferation of the MG63 human osteosarcoma cell line.

Authors:  Zheng-Xiao Ouyang; Xian-An Li
Journal:  Oncol Lett       Date:  2013-07-24       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.